Literature DB >> 24842555

The down-regulation of neuroligin-2 and the correlative clinical significance of serum GABA over-expression in Hirschsprung's disease.

Hongchao Yang1, Jianyi Niu, Jian Wang, Fan Zhang, Qiangye Zhang, Wentong Zhang, Aiwu Li.   

Abstract

The goal of this study was to investigate the expression level of neuroligin-2 in different colon tissue segments of children with Hirschsprung's disease (HSCR) and the correlative clinical significance of serum Gamma-Aminobutyric Acid (serum GABA) in HSCR. Neuroligin-2 was assessed by Immunohistochemistry staining method on routine paraffin section from different colon tissue segments of HSCR (ganglionic colonic segment, transitional colonic segment and aganglionic colonic segment). Western-blot analysis and real-time fluorescence quantitative PCR(qRT-PCR) were applied to compare and evaluate the expression levels of neuroligin-2 from three segments of HSCR, and we used Enzyme-linked Immunosorbent Assay (ELISA) method to detect and compare the serum GABA between HSCR and non-HSCR. Immunohistochemistry staining demonstrated that intensive neuroligin-2 staining was detected in the ganglion cells in the ganglionic colonic and transitional colonic segments from the HSCR children; however, neuroligin-2 staining was down-regulated significantly in the aganglionic colonic segments. The expression levels of neuroligin-2 mRNA and protein in the aganglionic colonic segment were decreased compared to the ganglionic colonic segment and transitional colonic segment (P < 0.05). And the level of serum GABA was significantly higher in HSCR than that in non-HSCR. The expression of neuroligin-2 varies from different segments of HSCR. The down-regulation of neuroligin-2 in aganglionic colonic segments may be correlated with the excessive intestine contraction and further result in HSCR. The over-expression of serum GABA may be considered as a new diagnostic method of HSCR.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24842555     DOI: 10.1007/s11064-014-1334-y

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  26 in total

1.  A balance between excitatory and inhibitory synapses is controlled by PSD-95 and neuroligin.

Authors:  Oliver Prange; Tak Pan Wong; Kimberly Gerrow; Yu Tian Wang; Alaa El-Husseini
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-09       Impact factor: 11.205

Review 2.  Genetic basis of Hirschsprung's disease.

Authors:  Paul K H Tam; Mercè Garcia-Barceló
Journal:  Pediatr Surg Int       Date:  2009-06-12       Impact factor: 1.827

Review 3.  Synaptic organizing complexes.

Authors:  Tabrez J Siddiqui; Ann Marie Craig
Journal:  Curr Opin Neurobiol       Date:  2010-09-09       Impact factor: 6.627

4.  Sensory regulation of neuroligins and neurexin I in the honeybee brain.

Authors:  Sunita Biswas; Judith Reinhard; John Oakeshott; Robyn Russell; Mandyam V Srinivasan; Charles Claudianos
Journal:  PLoS One       Date:  2010-02-09       Impact factor: 3.240

5.  Disturbances of colonic motility in mouse models of Hirschsprung's disease.

Authors:  Rachael R Roberts; Joel C Bornstein; Annette J Bergner; Heather M Young
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-02-14       Impact factor: 4.052

6.  Structures, alternative splicing, and neurexin binding of multiple neuroligins.

Authors:  K Ichtchenko; T Nguyen; T C Südhof
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

7.  Long segment and short segment familial Hirschsprung's disease: variable clinical expression at the RET locus.

Authors:  P Edery; A Pelet; L M Mulligan; L Abel; T Attié; E Dow; D Bonneau; A David; W Flintoff; D Jan
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

8.  Neuroligin 2 controls the maturation of GABAergic synapses and information processing in the retina.

Authors:  Mrinalini Hoon; Gabriele Bauer; Jean-Marc Fritschy; Tobias Moser; Bjoern H Falkenburger; Frédérique Varoqueaux
Journal:  J Neurosci       Date:  2009-06-24       Impact factor: 6.167

Review 9.  Enteric nervous system development and Hirschsprung's disease: advances in genetic and stem cell studies.

Authors:  Tiffany A Heanue; Vassilis Pachnis
Journal:  Nat Rev Neurosci       Date:  2007-06       Impact factor: 34.870

10.  Expression and significance of neuroligins in myenteric cells of Cajal in Hirschsprung's disease.

Authors:  Jian Wang; Yaru Mou; Qiangye Zhang; Fan Zhang; Hongchao Yang; Wentong Zhang; Aiwu Li
Journal:  PLoS One       Date:  2013-06-28       Impact factor: 3.240

View more
  5 in total

1.  Abundance and significance of neuroligin-1 and glutamate in Hirschsprung's disease.

Authors:  Jian Wang; Hao Du; Ya-Ru Mou; Jian-Yi Niu; Wen-Tong Zhang; Hong-Chao Yang; Ai-Wu Li
Journal:  World J Gastroenterol       Date:  2015-06-21       Impact factor: 5.742

2.  Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice.

Authors:  Mathusi Swaminathan; Elisa Hill-Yardin; Melina Ellis; Matthew Zygorodimos; Leigh A Johnston; Rachel M Gwynne; Joel C Bornstein
Journal:  J Vis Exp       Date:  2016-02-03       Impact factor: 1.355

3.  Abundance and Significance of Neuroligin-1 and Neurexin II in the Enteric Nervous System of Embryonic Rats.

Authors:  Dongming Wang; Jingnian Pan; Guoxin Song; Ni Gao; Yi Zheng; Qiangye Zhang; Aiwu Li
Journal:  Biomed Res Int       Date:  2017-01-18       Impact factor: 3.411

4.  Gastrointestinal dysfunction in patients and mice expressing the autism-associated R451C mutation in neuroligin-3.

Authors:  Suzanne Hosie; Melina Ellis; Mathusi Swaminathan; Fatima Ramalhosa; Gracia O Seger; Gayathri K Balasuriya; Christopher Gillberg; Maria Råstam; Leonid Churilov; Sonja J McKeown; Nalzi Yalcinkaya; Petri Urvil; Tor Savidge; Carolyn A Bell; Oonagh Bodin; Jen Wood; Ashley E Franks; Joel C Bornstein; Elisa L Hill-Yardin
Journal:  Autism Res       Date:  2019-05-22       Impact factor: 5.216

5.  Effect of Neuroligin1 and Neurexin1 on the Colonic Motility in a Mouse Model of Neuronal Intestinal Dysplasia.

Authors:  Dongming Wang; Ni Gao; Tingting Zhou; Qiangye Zhang; Jian Wang; Aiwu Li
Journal:  Gastroenterol Res Pract       Date:  2020-01-04       Impact factor: 2.260

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.